• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非典型 TERT 启动子突变的机制基础。

Mechanistic basis of atypical TERT promoter mutations.

机构信息

Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.

出版信息

Nat Commun. 2024 Nov 18;15(1):9965. doi: 10.1038/s41467-024-54158-5.

DOI:10.1038/s41467-024-54158-5
PMID:39557834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11574208/
Abstract

Non-coding mutations in the TERT promoter (TERTp), typically at one of two bases -124 and -146 bp upstream of the start codon, are among the most prevalent driver mutations in human cancer. Several additional recurrent TERTp mutations have been reported but their functions and origins remain largely unexplained. Here, we show that atypical TERTp mutations arise secondary to canonical TERTp mutations in a two-step process. Canonical TERTp mutations create de novo binding sites for ETS family transcription factors that induce favourable conditions for DNA damage formation by UV light, thus creating a hotspot effect but only after a first mutational hit. In agreement, atypical TERTp mutations co-occur with canonical driver mutations in large cancer cohorts and arise subclonally specifically on the TERTp driver mutant chromosome homolog of melanoma cells treated with UV light in vitro. Our study gives an in-depth view of TERTp mutations in cancer and provides a mechanistic explanation for atypical TERTp mutations.

摘要

非编码突变 TERT 启动子(TERTp),通常位于起始密码子上游的两个碱基-124 和-146bp 处,是人类癌症中最常见的驱动突变之一。已经报道了一些其他常见的 TERTp 突变,但它们的功能和起源在很大程度上仍未得到解释。在这里,我们表明,非典型 TERTp 突变是在两步过程中继发于典型 TERTp 突变而产生的。典型的 TERTp 突变创造了新的 ETS 家族转录因子结合位点,这些转录因子通过紫外线诱导 DNA 损伤形成有利条件,从而产生热点效应,但仅在第一次突变后才会产生。一致地,非典型 TERTp 突变与大的癌症队列中的典型驱动突变共同发生,并且仅在体外用紫外线处理黑色素瘤细胞的 TERTp 驱动突变体染色体同源物上亚克隆特异性地出现。我们的研究深入了解了癌症中的 TERTp 突变,并为非典型 TERTp 突变提供了一种机制解释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9075/11574208/0cddc05d45c5/41467_2024_54158_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9075/11574208/482967b89cde/41467_2024_54158_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9075/11574208/1a8ff76bfba9/41467_2024_54158_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9075/11574208/510535d0f3cb/41467_2024_54158_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9075/11574208/ab892e4d6369/41467_2024_54158_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9075/11574208/b10249afc33a/41467_2024_54158_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9075/11574208/0cddc05d45c5/41467_2024_54158_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9075/11574208/482967b89cde/41467_2024_54158_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9075/11574208/1a8ff76bfba9/41467_2024_54158_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9075/11574208/510535d0f3cb/41467_2024_54158_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9075/11574208/ab892e4d6369/41467_2024_54158_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9075/11574208/b10249afc33a/41467_2024_54158_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9075/11574208/0cddc05d45c5/41467_2024_54158_Fig6_HTML.jpg

相似文献

1
Mechanistic basis of atypical TERT promoter mutations.非典型 TERT 启动子突变的机制基础。
Nat Commun. 2024 Nov 18;15(1):9965. doi: 10.1038/s41467-024-54158-5.
2
New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma.新的体细胞 TERT 启动子变异增强胶质母细胞瘤中的端粒酶活性。
Acta Neuropathol Commun. 2020 Aug 25;8(1):145. doi: 10.1186/s40478-020-01022-4.
3
Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression.端粒酶逆转录酶启动子突变与甲基化相互作用最终导致染色质可及性和端粒酶逆转录酶表达。
PLoS One. 2020 Apr 8;15(4):e0231418. doi: 10.1371/journal.pone.0231418. eCollection 2020.
4
ETS Factor ETV5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid Cancer.ETS 因子 ETV5 在甲状腺癌中激活突变端粒酶逆转录酶启动子。
Thyroid. 2019 Nov;29(11):1623-1633. doi: 10.1089/thy.2018.0314. Epub 2019 Oct 29.
5
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.胶质瘤中的端粒酶逆转录酶(TERT)启动子突变、遗传关联及临床病理相关性
Br J Cancer. 2014 Nov 11;111(10):2024-32. doi: 10.1038/bjc.2014.538. Epub 2014 Oct 14.
6
Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot Mutations.颅咽管瘤,包括复发病例,缺乏 TERT 启动子热点突变。
Neurol Med Chir (Tokyo). 2021 Jun 15;61(6):385-391. doi: 10.2176/nmc.rc.2020-0339. Epub 2021 May 8.
7
Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma.获得性 TERT 启动子突变刺激套细胞淋巴瘤中的 TERT 转录。
Am J Hematol. 2016 May;91(5):481-5. doi: 10.1002/ajh.24324. Epub 2016 Apr 4.
8
TERT promoter mutations in primary and secondary WHO grade III meningioma.原发性和复发性世界卫生组织分级 III 级脑膜瘤中的 TERT 启动子突变。
Brain Pathol. 2021 Jan;31(1):61-69. doi: 10.1111/bpa.12892. Epub 2020 Sep 15.
9
TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.TERT 启动子野生型胶质母细胞瘤表现出独特的临床特征和频繁的 PI3K 通路突变。
Acta Neuropathol Commun. 2018 Oct 17;6(1):106. doi: 10.1186/s40478-018-0613-2.
10
TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.端粒酶逆转录酶(TERT)启动子突变与rs2853669多态性:对胶质母细胞瘤的预后影响及与常见改变的相互作用
J Neurooncol. 2016 Feb;126(3):441-6. doi: 10.1007/s11060-015-1999-3. Epub 2015 Nov 25.

引用本文的文献

1
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversible.端粒酶逆转录酶(TERT)启动子突变型癌症的永生机制具有自我强化性且是可逆的。
Mol Cell. 2025 Jun 19;85(12):2337-2354.e9. doi: 10.1016/j.molcel.2025.05.026. Epub 2025 Jun 12.
2
TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis.端粒酶逆转录酶-TP53突变:一种用于肝细胞癌复发和预后的新型生物标志物组合
Sci Rep. 2025 Jan 29;15(1):3620. doi: 10.1038/s41598-025-87545-z.

本文引用的文献

1
Base-resolution UV footprinting by sequencing reveals distinctive damage signatures for DNA-binding proteins.测序的碱基分辨率紫外足迹分析揭示了 DNA 结合蛋白的独特损伤特征。
Nat Commun. 2023 May 11;14(1):2701. doi: 10.1038/s41467-023-38266-2.
2
Detecting recurrent passenger mutations in melanoma by targeted UV damage sequencing.通过靶向紫外线损伤测序检测黑色素瘤中的复发性乘客突变。
Nat Commun. 2023 May 11;14(1):2702. doi: 10.1038/s41467-023-38265-3.
3
Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.
肿瘤队列中的体细胞突变分布为癌症中的正选择提供了信号。
Nat Commun. 2022 Nov 17;13(1):7023. doi: 10.1038/s41467-022-34746-z.
4
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer.TERT 启动子重复序列的保守特征揭示了一种激活机制,该机制模拟了癌症中的热点突变。
Nat Commun. 2022 Sep 16;13(1):5430. doi: 10.1038/s41467-022-33099-x.
5
UMIErrorCorrect and UMIAnalyzer: Software for Consensus Read Generation, Error Correction, and Visualization Using Unique Molecular Identifiers.UMIErrorCorrect 和 UMIAnalyzer:使用唯一分子标识符生成共识读、纠错和可视化的软件。
Clin Chem. 2022 Nov 3;68(11):1425-1435. doi: 10.1093/clinchem/hvac136.
6
AACR Project GENIE: 100,000 Cases and Beyond.AACR Project GENIE:10 万例及以上。
Cancer Discov. 2022 Sep 2;12(9):2044-2057. doi: 10.1158/2159-8290.CD-21-1547.
7
Occurrence, functionality and abundance of the TERT promoter mutations.TERT 启动子突变的发生、功能和丰度。
Int J Cancer. 2021 Dec 1;149(11):1852-1862. doi: 10.1002/ijc.33750. Epub 2021 Aug 4.
8
Non-coding driver mutations in human cancer.人类癌症中的非编码驱动突变。
Nat Rev Cancer. 2021 Aug;21(8):500-509. doi: 10.1038/s41568-021-00371-z. Epub 2021 Jul 6.
9
OncoTree: A Cancer Classification System for Precision Oncology.OncoTree:精准肿瘤学的癌症分类系统。
JCO Clin Cancer Inform. 2021 Feb;5:221-230. doi: 10.1200/CCI.20.00108.
10
Human TERT promoter mutations as a prognostic biomarker in glioma.人类端粒酶逆转录酶启动子突变作为胶质瘤的预后生物标志物。
J Cancer Res Clin Oncol. 2021 Apr;147(4):1007-1017. doi: 10.1007/s00432-021-03536-3. Epub 2021 Feb 6.